Celestica Inc offers supply chain solutions... Show more
Celestica is a Toronto-based electronics manufacturing services (EMS) company that designs, engineers, and manufactures complex hardware for original equipment manufacturers across communications, cloud, aerospace and defense, industrial, and healthcare markets. Its forward-looking story, however, is increasingly defined by its Connectivity & Cloud Solutions (CCS) segment, which now generates roughly four-fifths of total revenue and is anchored to the rapid buildout of AI data-center infrastructure.
The company's key differentiator is its shift toward design-led, higher-value work. Its Hardware Platform Solutions (HPS) business—where Celestica's own engineering is embedded in the product rather than layered around contract assembly—grew faster than the company overall in recent quarters, reflecting leadership in high-speed networking switches and enterprise server programs. This design content commands stronger pricing and supports the operating leverage that is lifting margins.
Competitively, Celestica faces large, well-capitalized rivals such as Jabil, Flex, and Sanmina in the EMS and AI-infrastructure space. Yet Celestica's deepening relationships with hyperscalers, including Alphabet, Meta, and Amazon, along with emerging programs tied to OpenAI and AMD, signal meaningful market-share gains in data-center switching and scale-up computing. The strategic risk is that this concentration leaves the company exposed to any deceleration in a handful of customers' capital-spending plans.
Several near-term events could materially shape investor sentiment around Celestica's future outlook. The company's next quarterly earnings report, expected in late October 2026, is the most immediate catalyst, given that each of the last two reports delivered results above the high end of guidance and prompted full-year outlook increases.
Product-cycle momentum is equally important. Management has cited ten active 1.6T networking programs, with mass production beginning at two hyperscaler customers in the third quarter of 2026 and broader acceleration into 2027. A co-packaged optics program is expected to begin sampling in the first half of 2027 and enter mass production later that year—an innovation cycle that could extend Celestica's networking leadership.
On the compute side, Celestica will manufacture advanced AI racks developed with Broadcom to support OpenAI's custom accelerator roadmap, with initial deliveries anticipated in late 2026 and mass production in 2027. The AMD Helios scale-up platform adds a second multibillion-dollar program. Each of these ramps could drive upward analyst revisions.
Analyst sentiment has been trending more optimistic rather than mixed. The consensus rating on the stock is a Strong Buy, with the average one-year price target recently around $470–$477, according to S&P Global and other aggregators, and targets from individual firms ranging from roughly $415 to $550. Recent actions—including upgrades, coverage initiations, and raised price targets from firms such as TD Cowen, UBS, RBC Capital, Susquehanna, and CIBC—reflect growing confidence that Street estimates remain too low.
Celestica's trajectory is tightly linked to hyperscaler capital expenditure (capex) cycles rather than broad consumer demand. Sustained investment in AI data centers—spanning compute, networking, storage, and power—is the dominant industry tailwind, and management has pointed to customer visibility extending as far as 2029 in some cases. This structural spending wave supports multi-year revenue growth assumptions.
Interest rates and inflation remain relevant but secondary. Elevated borrowing costs could pressure the financing of large capital projects, yet hyperscalers have so far prioritized AI infrastructure spending. On the cost side, component availability—not demand—is Celestica's binding constraint, with some lead times stretching well beyond normal levels. This dynamic can compress short-term revenue recognition while simultaneously strengthening pricing power and order visibility.
Geopolitics and trade policy add another layer of sensitivity. Celestica's global manufacturing footprint, including capacity expansion in Thailand, Japan, and Texas, reflects an effort to diversify supply chains and mitigate tariff and export-control risks. Regulatory scrutiny of AI compute exports or changes to trade frameworks could influence both customer demand and production economics.
The Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to keep users informed as conditions evolve. For investors monitoring fast-moving names like Celestica, combining fundamental catalysts with an AI-driven technical signal can add a useful second perspective.
Looking ahead to 2026 and beyond, Celestica's outlook hinges on whether it can sustain the operating leverage that has allowed earnings to grow faster than revenue. Management has guided to full-year 2026 revenue of about $20.5 billion—roughly 65% growth—with adjusted EPS near $11.30, and has indicated that 2027 revenue growth could accelerate further. A preliminary 2027 framework pointing toward roughly $34 billion in revenue and $20 in EPS sits well above prevailing consensus, according to CIBC, suggesting continued upward revision potential.
Long-term structural drivers include the transition from 400G and 800G networking to 1.6T and co-packaged optics, the expansion of custom AI rack and scale-up computing programs, and growth in the Advanced Technology Solutions (ATS) segment, where wafer-fab equipment demand is expected to remain a tailwind into 2027. Margin sustainability will depend on the mix of higher-value HPS work versus lower-margin assembly, as well as gross-margin management through large program ramps.
Key risks include customer concentration among a small number of hyperscalers, potential pauses or reprioritization in AI capex, supply-chain bottlenecks, and dilution from capital raises. Competitive threats from Jabil, Flex, and others also warrant monitoring. While analyst ratings and price targets are broadly positive, these figures represent external expectations rather than guarantees, and the trajectory will ultimately be tested by execution through a period of unprecedented growth.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of electronics manufacturing services
Industry ElectronicComponents
A.I.dvisor indicates that over the last year, CLS has been loosely correlated with FN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CLS jumps, then FN could also see price increases.
| Ticker / NAME | Correlation To CLS | 1D Price Change % | ||
|---|---|---|---|---|
| CLS | 100% | +1.61% | ||
| FN - CLS | 65% Loosely correlated | -0.73% | ||
| TTMI - CLS | 59% Loosely correlated | -1.29% | ||
| FLEX - CLS | 55% Loosely correlated | -1.88% | ||
| GLW - CLS | 53% Loosely correlated | -3.26% | ||
| APH - CLS | 51% Loosely correlated | -0.78% | ||
More | ||||
The 10-day moving average for CLS crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on September 03, 2026. You may want to consider a long position or call options on CLS as a result. In 65 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for CLS just turned positive on September 04, 2026. Looking at past instances where CLS's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
CLS moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLS advanced for three days, in 308 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
CLS broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CLS entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLS's P/B Ratio (18.416) is very high in comparison to the industry average of (5.588). P/E Ratio (37.577) is within average values for comparable stocks, (82.208). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (1.692). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.388) is also within normal values, averaging (4.796).
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.